A breakthrough experimental drug has shown promising results in shrinking advanced prostate cancer tumours, offering new hope ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Nuvalent's NVL-655 and Zidesamtinib show strong potential as first-line therapies for NSCLC. Click here to find out why I ...

Professor Markus Sauer from the Biocentre of Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany ...

Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

The Head and Neck Radiation Oncology Group (GORTEC) announced significant improvement in disease-free survival for locally ...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

Ukraine latest: Russian officials 'frustrated' with Putin - as Moscow responds to Trump plans to meet Kremlin leader The Kremlin has been discussing Donald Trump's claims that a meeting between ...

Middle Eastcategory US, Arab mediators make some progress in Gaza talks, no deal yet, sources say January 10, 2025 Reuters, the news and media division of Thomson Reuters, is the world’s largest ...